American Journal of Pathology: Periostin Shows Promise to Help Fight a Common Form of Esophageal Cancer
April 10, 2024
April 10, 2024
PHILADELPHIA, Pennsylvania, April 10 (TNSres) -- The American Journal of Pathology, the journal of the American Society for Investigative Pathology, issued the following news release:
* * *
Periostin may be a promising novel therapeutic target for treating esophageal squamous cell carcinoma, reports The American Journal of Pathology
* * *
Esophageal squamous cell carcinoma (ESCC) accounts for around 90% of esophageal cancers, especially in Eas . . .
* * *
Periostin may be a promising novel therapeutic target for treating esophageal squamous cell carcinoma, reports The American Journal of Pathology
* * *
Esophageal squamous cell carcinoma (ESCC) accounts for around 90% of esophageal cancers, especially in Eas . . .